Showing 1 posts of 1 posts found.
Novozymes subsidiary Albumedix has scored another big pharma tie-up for its albumin-based half-life extension technology VELTIS, which this time is …
PinPoint signs laboratory partnership to expand access to AI cancer risk test
NHS expands community ear and hearing pathway across 10 ICBs
London secures major investment to accelerate healthcare innovation
People with severe mental illness more likely to die early from cardiovascular disease, report finds
Yourgene wins Australian approval for chemotherapy toxicity screening assay